methyl 2-(5-formyl-2-hydroxyphenoxy)acetate | 1346225-92-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2-(5-formyl-2-hydroxyphenoxy)acetate
• CAS: 1346225-92-0
• 化学式: C₁₀H₁₀O₅
• 分子量: 210.186
• InChiKey: DCJDTDJELBHEHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 2-(5-formyl-2-hydroxyphenoxy)acetate 在 哌啶 、 potassium carbonate 、 溶剂黄146 、 potassium iodide 、 lithium hydroxide 作用下， 以 甲醇 、 乙醇 、 水 、 乙腈 为溶剂， 反应 5.67h， 生成 (R,Z)-2-(4-((2-(carboxymethoxy)-4-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)phenoxy)methyl)benzamido)pentanedioic acid
  参考文献：
  名称：

  New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: Design, synthesis, crystal structures, and biological evaluation

  摘要：

  Mur ligases (MurC-MurF), a group of bacterial enzymes that catalyze four consecutive steps in the formation of cytoplasmic peptidoglycan precursor, are becoming increasingly adopted as targets in antibacterial drug design. Based on the crystal structure of MurD cocrystallized with thiazolidine-2,4-dione inhibitor I, we have designed, synthesized, and evaluated a series of improved glutamic acid containing 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD with IC50 values up to 28 mu M. Inhibitor 37, with an IC50 of 34 mu M, displays a weak antibacterial activity against S. aureus ATCC 29213 and E. faecalis ATCC 29212 with minimal inhibitory concentrations of 128 mu g/mL. High-resolution crystal structures of MurD in complex with two new inhibitors (compounds 23 and 51) reveal details of their binding modes within the active site and provide valuable information for further structure-based optimization. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.09.017
• 作为产物：
  描述：

  methyl 2-(2-(benzyloxy)-5-formylphenoxy)acetate 在 甲醇 作用下， 以 甲苯 为溶剂， 反应 5.0h， 以71%的产率得到methyl 2-(5-formyl-2-hydroxyphenoxy)acetate
  参考文献：
  名称：

  New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: Design, synthesis, crystal structures, and biological evaluation

  摘要：

  Mur ligases (MurC-MurF), a group of bacterial enzymes that catalyze four consecutive steps in the formation of cytoplasmic peptidoglycan precursor, are becoming increasingly adopted as targets in antibacterial drug design. Based on the crystal structure of MurD cocrystallized with thiazolidine-2,4-dione inhibitor I, we have designed, synthesized, and evaluated a series of improved glutamic acid containing 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD with IC50 values up to 28 mu M. Inhibitor 37, with an IC50 of 34 mu M, displays a weak antibacterial activity against S. aureus ATCC 29213 and E. faecalis ATCC 29212 with minimal inhibitory concentrations of 128 mu g/mL. High-resolution crystal structures of MurD in complex with two new inhibitors (compounds 23 and 51) reveal details of their binding modes within the active site and provide valuable information for further structure-based optimization. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.09.017

文献信息

• Engineering Orthogonal Methyltransferases to Create Alternative Bioalkylation Pathways
  作者：Abigail J. Herbert、Sarah A. Shepherd、Victoria A. Cronin、Matthew R. Bennett、Rehana Sung、Jason Micklefield

  DOI：10.1002/anie.202004963

  日期：2020.8.24

  the methylation of a vast array of small metabolites and biomacromolecules. Recently, rare carboxymethylation pathways have been discovered, including carboxymethyltransferase enzymes that utilise a carboxy‐SAM (cxSAM) cofactor generated from SAM by a cxSAM synthase (CmoA). We show how MT enzymes can utilise cxSAM to catalyse carboxymethylation of tetrahydroisoquinoline (THIQ) and catechol substrates

  S-腺苷-L-甲硫氨酸（SAM）依赖性甲基转移酶（MT）催化大量小代谢物和生物大分子的甲基化。最近，发现了罕见的羧甲基化途径，包括利用 cxSAM 合酶 (CmoA) 从 SAM 生成的羧基 SAM (cxSAM) 辅因子的羧甲基转移酶。我们展示了 MT 酶如何利用 cxSAM 催化四氢异喹啉 (THIQ) 和儿茶酚底物的羧甲基化。定点诱变用于创建正交 MT，其对 cxSAM 具有改进的催化活性和选择性，随后与 CmoA 偶联，导致更有效和选择性的羧甲基化。还开发了一种酶促方法来生成以前未描述的辅因子羧基-S-腺苷-L-乙硫氨酸（cxSAE），从而能够将手性1-羧乙基立体选择性转移到底物上。
• New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: Design, synthesis, crystal structures, and biological evaluation
  作者：Nace Zidar、Tihomir Tomašić、Roman Šink、Andreja Kovač、Delphine Patin、Didier Blanot、Carlos Contreras-Martel、Andréa Dessen、Manica Müller Premru、Anamarija Zega、Stanislav Gobec、Lucija Peterlin Mašič、Danijel Kikelj

  DOI：10.1016/j.ejmech.2011.09.017

  日期：2011.11

  Mur ligases (MurC-MurF), a group of bacterial enzymes that catalyze four consecutive steps in the formation of cytoplasmic peptidoglycan precursor, are becoming increasingly adopted as targets in antibacterial drug design. Based on the crystal structure of MurD cocrystallized with thiazolidine-2,4-dione inhibitor I, we have designed, synthesized, and evaluated a series of improved glutamic acid containing 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD with IC50 values up to 28 mu M. Inhibitor 37, with an IC50 of 34 mu M, displays a weak antibacterial activity against S. aureus ATCC 29213 and E. faecalis ATCC 29212 with minimal inhibitory concentrations of 128 mu g/mL. High-resolution crystal structures of MurD in complex with two new inhibitors (compounds 23 and 51) reveal details of their binding modes within the active site and provide valuable information for further structure-based optimization. (C) 2011 Elsevier Masson SAS. All rights reserved.